Maternus-Kliniken Aktiengesellschaft (F:MAK) — Market Cap & Net Worth
Market Cap & Net Worth: Maternus-Kliniken Aktiengesellschaft (MAK)
Maternus-Kliniken Aktiengesellschaft (F:MAK) has a market capitalization of $18.85 Million (€16.12 Million) as of September 17, 2026. Listed on the F stock exchange, this Germany-based company holds position #25401 globally and #2173 in its home market, demonstrating a -0.60% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Maternus-Kliniken Aktiengesellschaft's stock price €0.84 by its total outstanding shares 20970000 (20.97 Million). Also see Maternus-Kliniken Aktiengesellschaft asset portfolio for a full breakdown of the balance sheet.
Maternus-Kliniken Aktiengesellschaft Market Cap History: 2015 to 2026
Maternus-Kliniken Aktiengesellschaft's market capitalization history from 2015 to 2026. Data shows change from $32.17 Million to $20.47 Million (-5.49% CAGR). Also see cash flow conversion of Maternus-Kliniken Aktiengesellschaft for how efficiently the company converts equity into cash flow.
Maternus-Kliniken Aktiengesellschaft Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Maternus-Kliniken Aktiengesellschaft's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Maternus-Kliniken Aktiengesellschaft stock quote for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.20x
Maternus-Kliniken Aktiengesellschaft's market cap is 0.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $31.60 Million | $124.04 Million | $1.10 Million | 0.25x | 28.62x |
| 2017 | $56.09 Million | $127.14 Million | -$1.46 Million | 0.44x | N/A |
| 2018 | $42.90 Million | $124.28 Million | -$1.57 Million | 0.35x | N/A |
| 2019 | $46.83 Million | $124.43 Million | -$10.26 Million | 0.38x | N/A |
| 2020 | $100.52 Million | $114.30 Million | -$9.62 Million | 0.88x | N/A |
| 2021 | $117.19 Million | $111.44 Million | -$2.48 Million | 1.05x | N/A |
| 2022 | $39.23 Million | $106.70 Million | -$14.08 Million | 0.37x | N/A |
| 2023 | $68.15 Million | $102.31 Million | -$14.26 Million | 0.67x | N/A |
| 2024 | $33.34 Million | $114.00 Million | -$13.16 Million | 0.29x | N/A |
| 2025 | $23.78 Million | $118.03 Million | -$13.85 Million | 0.20x | N/A |
Competitor Companies of MAK by Market Capitalization
Companies near Maternus-Kliniken Aktiengesellschaft in the global market cap rankings as of September 17, 2026. Review Maternus-Kliniken Aktiengesellschaft (MAK) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Maternus-Kliniken Aktiengesellschaft by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #288 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #911 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1001 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1234 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #288 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $423.82 |
| #911 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.39 |
| #1001 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1234 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $260.85 |
Maternus-Kliniken Aktiengesellschaft Historical Marketcap From 2015 to 2026
Between 2015 and today, Maternus-Kliniken Aktiengesellschaft's market cap moved from $32.17 Million to $ 20.47 Million, with a yearly change of -5.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €20.47 Million | -13.92% |
| 2025 | €23.78 Million | -28.68% |
| 2024 | €33.34 Million | -51.08% |
| 2023 | €68.15 Million | +73.75% |
| 2022 | €39.23 Million | -66.53% |
| 2021 | €117.19 Million | +16.59% |
| 2020 | €100.52 Million | +114.66% |
| 2019 | €46.83 Million | +9.14% |
| 2018 | €42.90 Million | -23.51% |
| 2017 | €56.09 Million | +77.50% |
| 2016 | €31.60 Million | -1.75% |
| 2015 | €32.17 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Maternus-Kliniken Aktiengesellschaft was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.85 Million USD |
| MoneyControl | $18.85 Million USD |
| MarketWatch | $18.85 Million USD |
| marketcap.company | $18.85 Million USD |
| Reuters | $18.85 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Maternus-Kliniken Aktiengesellschaft
Maternus-Kliniken Aktiengesellschaft operates senior citizen homes, care facilities, rehabilitation clinics in Germany. The company also provides specialized services in geriatric care and rehabilitation medicine. It also offers full-time inpatient care, assisted living, outpatient care, and home emergency call services. Maternus-Kliniken Aktiengesellschaft was founded in 1877 and is headquartere… Read more